BIONOVA X
Lighting up high resolution,high throughput 3D bioprinting

Create the future of healthFeatures Designed
For Your Success

Ultra High Resolution

2Direct in-Well Printing

Print down to 10μm resolution
enabling effortless
microarchitecture bioprinting

High-throughput culture and assay
ready, no sample transfer needed in6, 12 or 24 well-plates

Cell Friendly Printing

Unparalleled Speed

Leveraging a 405nm lightsource for minimal damage
to cells during printing.

Utilizing a patented continuous printing
technology print faster than ever before
without sacrificing print fidelity.

Auto AlignmentTemperature Control

No manual alignment
or focusing needed

Provide optimal printing
conditions for your bioinks

CELLINK

AcceleratingYour Research
Accelerating your research in Biomimetic Models, Regenerative
Medicine, Precision Medicine and Disease Modelling.
We offer the world’s first digital light processing(DLP)-based bioprinter for direct printing in multiwell plates. Our rapid 3D bioprinter can printcomplex 3D structures, with superior resolution,
speed, flexibility and scalability from computer
aided design (CAD) models or medical images.
The visible light-induced polymerization mecha-nism also allows for the incorporation of various
cell types with functional biomaterials to directly print functional tissue models in a matter ofseconds. Strengthening research with high resolution, reproducibility and high speed light based
bioprinting across key application areas setting
up for convenient downstream analysis.

BIONOVA X BROCHURE

3

REGENERATIVE MEDICINE

From medical images
to 3D Models• Print implantable scale devices fit to patient
requirements for personalized therapies​• Develop constructs with the physiologicallyrelevant biomechanical properties ​​​Spinal CordPeripheral Nerve

BIOMIMETIC MODELS

Effortlessly recapitulate invivo biomechanical properties​​• Regionally vary stiffness with grayscale printing
to create gradients mimicking in vivo conditions. ​• Print with cells at high speed, maximizing cellviability. ​Liver ​4CELLINKNerve​

Heart​

PRECISION MEDICINE​

Drive vascularization for moremeaningful tissue engineering​• Consistent fabrication of lumen like structures​• High speed printing for cell-based constructs

Liver ​

Vascularized Tissue ​DISEASE MODELLING

Control microarchitecture torecreate disease like conditions​• Develop models that direct cell behaviour tomodel disease like conditions ​• Print in up to 24 well plates for high throughput
screening assays• Create models ideal for long term tissue maturation​

Cardiac​

Kidney​Cancer ​BIONOVA X BROCHURE

5Streamlined Operation
Exceptional design to maximize output and efficiency

Easily Fits in a
Biosafety Cabinet

Built-in UVC
Sterlization for
optimal sterility

Built in computerfor seamlessprotocol set up

Glove Friendly
10” Touch Screen

User-Friendly
Interface

Supports STL
files as well as
image files

6CELLINK

Specifications
3D Bioprinting technology

Direct in-well layerless printing with digital light projection-based technology

Printing resolution (XY)

10 μm

Z-precision (motor driven)

4 μm

LED wavelength

405 nm (FWHM ±7.5nm)

Intensity range

4-16 mW/cm2

Heater temperature

Room temperature to 60 °C

Well plate format

24 well plate, 12 well plate, 6 well plate

Build volume

24 well plate63.6 mm2 (Ø 9 mm) x 6.5 (Z) mm

12 well plate

9.0 mm (X) x 9.0 mm (Y) x 9 mm (Z)

6 well plate19.2 mm (X) x 10.8 mm (Y) x 9 mm (Z)Build plate calibration

Auto alignmentDisplay

10” touch screen, glove friendlyConnectivity

1x USB port (type A)

SoftwareOn-board software

Support file types.stl, .png, .bmp, .jpg

Sterility

UVC sterilization of chamber (270 ± 10nm)

Dimensions

20.3” (W) x 15” (D) x 17.4” (H)
515 mm (W) x 380 mm (D) x 441 mm (H)Weight90 lbs (41 kg)

Power supply input

100-240VAC, 50-60Hz, 200W

BIONOVA X BROCHURE

7CELLINK, A BICO COMPANYCELLINK is creating the future of health as part of BICO, the world’s leading bioconvergence company. When CELLINK released the first universal bioink in 2016, it democratized the cost of entry
for researchers around the world and played a major role in turning the then up-and-coming fieldof 3D bioprinting into a thriving $1 billion industry. Today, the company’s best-in-class bioinks, bioprinters, software and services have been cited in over 700 publications and are trusted by morethan 1,000 academic, pharmaceutical and industrial labs. At the forefront of the bioprinting industry, CELLINK aims to alleviate organ donor shortage with biofabricated transplantable organs
and remains committed to reducing our dependence on animal testing and increasing efficiencies
in drug development with more physiologically relevant bioprinted organ models. Visit cellink.com
to learn more. BICO is listed on the Nasdaq Stockholm Main Market under BICO.

Email: sales@cellink.com | Website: www.cellink.com
US Phone: 1 (833) 235-5465 | EU Phone: 46 31-12 87 00